ACTU
Actuate Therapeutics, Inc. Common stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Actuate Therapeutics (ACTU) Stock: Buy, Sell, or Hold?
$0.31
+0.01 (+3.27%)
▲
5d:
-17.09%
30d:
-34.23%
90d:
-68.55%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
TODAY
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (88%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$0.33 – $0.65
Position: OVERSOLD
Forward P/E & Valuation
-0.5x
Next 12M consensus est.
Wall Street Target
$11.68
+3833.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.29 / $0.42
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ACTU is down 17.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ACTU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ACTU is currently trading at $0.31, which is considered oversold relative to its 30-day fair value range of $0.33 to $0.65.
Technical Outlook: Technically, ACTU is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.42. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.68 (+3833.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ACTU is in a strong downtrend. Immediate support is located at $0.29, while resistance sits at $0.42. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.68 (+3833.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.33 -
$0.65
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
Trading Range & Key Levels
30-Day Trading Range
$0.33 -
$0.65
Current vs Trading Range
OVERSOLD
Support Level
$0.29
Resistance Level
$0.42
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 3833.8% below Wall St target ($11.68)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.45
Wall Street Target
$11.68
(+3833.8%)
Share ACTU Analysis
Share this live ACTU analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ACTU)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 20, 2026
Daily AI digest
AI Retail Discussion Summary:
User on StockTwits expresses a bullish outlook on $ACTU with no new information provided in recent Yahoo Finance news.
Key Retail Themes:
Bullish sentiments
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 2:51 PM ET
Data refreshes hourly during market hours. Next update: 3:51 PM
Data refreshes hourly during market hours. Next update: 3:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACTU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 43 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ACTU Research Pages
